SEC Filing Summary: AspenBio Pharma, Inc.
Business Context and Reporting Period
This Form 8-K Current Report was filed by AspenBio Pharma, Inc. on August 8, 2011. The filing serves to disclose a PowerPoint presentation (Exhibit 99.1) intended for use at the CANACCORD/Genuity 31st Annual Growth Conference on August 9, 2011. Note: The request metadata listed "Riot Platforms, Inc.", but the source text explicitly identifies the registrant as AspenBio Pharma, Inc.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a presentation rather than a financial statement.
Material Changes
No material financial changes versus a prior period are detailed in this document. The filing solely incorporates a presentation by reference under Regulation FD.
Guidance, Outlook, and Risks
Management commentary, guidance, and risk factors are contained within the referenced PowerPoint presentation (Exhibit 99.1), which is available on the company's website. The filing text itself does not summarize these items.
Key Facts for Investor Verification
- Verify the content of the PowerPoint presentation (Exhibit 99.1) on the company website for actual financial data and strategic outlook.
- Confirm the discrepancy between the requested company name (Riot Platforms) and the actual registrant (AspenBio Pharma).
- Note that this filing is a procedural disclosure for an upcoming conference presentation, not a standalone financial report.